Study title:
AN 2003220170 20030626.
TI Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose.
AU Yuan-C-M, Spandorfer-P-R, Miller-S-L, Henretig-F-M, Shaw-L-M.
IN Dr. L.M. Shaw, Clinical Toxicology Laboratory, Department of Pathology, Univ. of Pennsylvania Medical Center, 3400 Spruce Street, Philadelphia, PA 19104, United States
e-mail: shawlmj@mail.med.upenn.edu.
SO Therapeutic Drug Monitoring {THER-DRUG-MONIT}, 2003, Vol/Iss/Pg. 25/3 (299-304), ISSN: 0163-4356. YR 2003.AN 2003220170 20030626.
TI Evaluation of tricyclic antidepressant false positivity in a pediatric case of cyproheptadine (periactin) overdose.
AU Yuan-C-M, Spandorfer-P-R, Miller-S-L, Henretig-F-M, Shaw-L-M.
IN Dr. L.M. Shaw, C...
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Behavior and Behavior Mechanisms [F01]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CYPROHEPTADINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|